SynopsisW
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care
C. Nadine Wathen, Denice S. Feig, John W. Feightner, Beth L. Abramson, Angela M. Cheung and ; and The Canadian Task Force on Preventive Health Care
CMAJ May 11, 2004 170 (10) 1535-1537; DOI: https://doi.org/10.1503/cmaj.1030756
C. Nadine Wathen
Denice S. Feig
John W. Feightner
Beth L. Abramson
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care
C. Nadine Wathen, Denice S. Feig, John W. Feightner, Beth L. Abramson, Angela M. Cheung
CMAJ May 2004, 170 (10) 1535-1537; DOI: 10.1503/cmaj.1030756
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care
C. Nadine Wathen, Denice S. Feig, John W. Feightner, Beth L. Abramson, Angela M. Cheung
CMAJ May 2004, 170 (10) 1535-1537; DOI: 10.1503/cmaj.1030756
Jump to section
Related Articles
Cited By...
- Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause
- Complete health checkup for adults: Update on the Preventive Care Checklist Form(C)
- Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care